Leader in AI-Driven Energy Solutions January 2022 1 Cautionary Statement Regarding Forward-Looking Statements This presentation, as well as other statements we make, contains "forward-looking statements" within the meaning of the federal securities laws, which include any statements that are not historical facts. Such statements often contain words such as "expect," "may," "can," "believe," "predict," "plan," "potential," "projected," "projections," "forecast," "estimate," "intend," "anticipate," "ambition, ...

September 2023 Investor Presentation Cautionary Statement Regarding Forward-Looking Statements This presentation, as well as other statements we make, contains "forward-looking statements" within the meaning of the federal securities laws, which include any statements that are not historical facts. Such statements often contain words such as "expect," "may," "can," "believe," "predict," "plan," "potential," "projected," "projections," "forecast," "estimate," "intend," "anticipate," "ambition," "goal," "targ ...

The price trend for Stem, Inc. (STEM) has been bearish lately and the stock has lost 16% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts ab ...

Core Insights - The Plant Stem Cell Market is projected to grow from USD 401.02 Million in 2024 to USD 635.54 Million by 2030, with a CAGR of 8.12% [2][9] - The market intersects biotechnology, healthcare, agriculture, and cosmetics, focusing on plant-derived stem cells for various applications [2][3] Market Drivers - Rising consumer preference for natural and organic products is a significant growth driver, as consumers favor plant-based ingredients over synthetic ones [4] - The demand for plant stem cells in skincare and personal care is driven by their antioxidant and rejuvenating properties, particularly in anti-aging and skin repair [4] - The expanding elderly population and increased awareness of regenerative solutions are fueling demand in the cosmetic and healthcare sectors [3] Market Challenges - Regulatory hurdles and compliance issues present considerable challenges, with a lack of globally harmonized regulations complicating product approval and commercialization [5] - Ethical sourcing concerns, especially regarding rare or endangered plant species, add complexity to product development and operational costs [5] Market Trends - There is a growing focus on sustainable and ethical sourcing, with manufacturers prioritizing environmentally responsible extraction methods and sustainable cultivation practices [6] - Companies that commit to transparency and sustainable innovation are likely to gain competitive advantages, influenced by eco-conscious consumers [6] Key Players - Notable companies in the Plant Stem Cell Market include Uniliver PLC, Renature Skin Care Inc., PhytoScience Ltd., and Oriflame Cosmetics AG [7]

Core Viewpoint - Stem's stock has significantly outperformed the broader technology sector, driven by strong first-quarter 2025 results and strategic shifts towards a software-centric business model [1][2]. Financial Performance - Total revenues for the first quarter of 2025 increased by 27% year over year, surpassing Zacks Consensus Estimates by 26% [2] - Gross margins improved by 46%, attributed to growth in high-margin software and services [3] - Annual recurring revenue (ARR) reached $57 million, an 8% increase year over year, while contracted annual recurring revenue (CARR) grew 7% sequentially to $69 million [5] - The company generated positive cash flow of $8.5 million from operations for the first time [3] Operational Metrics - Solar operating AUM increased to 32.4 GW, a 20% year-over-year rise, while storage operating AUM doubled to 1.6 GWh [6] - Bookings for the quarter were $34.5 million, slightly below the previous year's $37.6 million, but contracted backlog rose 21% sequentially to $25.3 million [6] Organizational Changes - Stem has undergone a significant organizational transformation, creating four distinct business units with full profit and loss accountability [7] - A targeted workforce reduction of 27% was announced, expected to save approximately $30 million annually, with a $24 million benefit anticipated in 2025 [8] Future Outlook - The company reaffirmed its 2025 revenue guidance, projecting between $125 million and $175 million, with a consensus estimate of $145.20 million [10] - The bottom line is expected to improve significantly, with a projected loss of 51 cents per share compared to a loss of $1.04 per share in the prior year [10] Conclusion - Stem's strong first-quarter performance, growing recurring revenue, and positive cash flow indicate strategic momentum and a path towards sustainable profitability [11]

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead ...

Stem (STEM) Q1 2025 Earnings Call April 29, 2025 09:48 PM ET Speaker0 Greetings, and welcome to the Stem Inc. First Quarter twenty twenty five Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference call is being recorded. It is now my pleasure to introduce Ted Durbin, Head of Investor Relations. Please go ahead. Speaker1 Thank you, operator. This is Ted Durbin, Head of Investor Relat ...

April 29, 2025 1Q 2025 Financial Results Cautionary Statement Regarding Forward-Looking Statements This presentation, as well as other statements we make, contains "forward-looking statements" within the meaning of the federal securities laws, which include any statements that are not historical facts. Such statements often contain words such as "expect," "may," "can," "believe," "predict," "plan," "potential," "projected," "projections," "forecast," "estimate," "intend," "anticipate," "ambition," "goal," " ...

Stem, Inc. (STEM) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced a loss of $0.12, delivering a surprise of 25%. Over the last four quarters, the company has surpassed consens ...

Stem (STEM) Q1 2025 Earnings Call April 29, 2025 05:00 PM ET Company Participants Ted Durbin - Vice President - Investor RelationsArun Narayanan - CEODoran Hole - CFODylan Nassano - Vice President Conference Call Participants Justin Clare - MD & Research AnalystThomas Boyes - Analyst Operator Greetings, and welcome to the Stem Inc. First Quarter twenty twenty five Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentat ...